Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2611 AL 2625

New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications

Akhtar RS, Stern MB.

Expert Rev Neurother. 2012 Dec;12(12):1429-38. doi: 10.1586/ern.12.144.

Drug treatments for the neuropsychiatric complications of Parkinson's disease

Connolly BS, Fox SH.

Expert Rev Neurother. 2012 Dec;12(12):1439-49. doi: 10.1586/ern.12.142.

Neurobiology of cognitive impairment in Parkinson's disease

Jellinger KA.

Expert Rev Neurother. 2012 Dec;12(12):1451-66. doi: 10.1586/ern.12.131.

Brain iron accumulation in aging and neurodegenerative disorders

Hagemeier J, Geurts JJ, Zivadinov R.

Expert Rev Neurother. 2012 Dec;12(12):1467-80. doi: 10.1586/ern.12.128.

Stem cells and neurodegenerative diseases: where is it all going?

Barker RA.

Regen Med. 2012 Nov;7(6 Suppl):26-31. doi: 10.2217/rme.12.64.

[Manganism--neurodegenerative brain disease caused by poisoning with manganese]

Rybakowska I, Kaletha K, Sein Anand J.

Przegl Lek. 2012;69(8):555-6.

C. elegans as a genetic model system to identify Parkinson's disease-associated therapeutic targets

Vistbakka J, VanDuyn N, Wong G, Nass R.

CNS Neurol Disord Drug Targets. 2012 Dec;11(8):957-64. doi: 10.2174/1871527311211080004.

Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death

Kumar H, Koppula S, Kim IS, More SV, Kim BW, Choi DK.

CNS Neurol Disord Drug Targets. 2012 Dec;11(8):1015-29. doi: 10.2174/1871527311211080012.

Environmental toxicants as extrinsic epigenetic factors for parkinsonism: studies employing transgenic C. elegans model

Jadiya P, Nazir A.

CNS Neurol Disord Drug Targets. 2012 Dec;11(8):976-83. doi: 10.2174/1871527311211080006.

[The optimization of using levodopa in patients with Parkinson's disease: results of the OPTIMA study]

Datieva VK, Makotrova TA, Levin OS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(10 Pt 2):13-9.

When can ablation be considered a reasonable option in young asymptomatic patients with a Wolff-Parkinson-White ECG?

Obeyesekere MN, Sy RW, Modi S.

Expert Rev Cardiovasc Ther. 2012 Dec;10(12):1451-3. doi: 10.1586/erc.12.146.

Prospective use of skin-derived precursors in neural regeneration

Lu XC, Tao Y, Li LX.

Chin Med J (Engl). 2012 Dec;125(24):4488-96.

PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy

Shiba-Fukushima K, Imai Y, Yoshida S, Ishihama Y, Kanao T, Sato S, Hattori N.

Sci Rep. 2012;2:1002. doi: 10.1038/srep01002. Epub 2012 Dec 19.

[P21-activated kinases and their role in the nervous system]

Qin Y, Ding YM, Xia Q.

Sheng Li Xue Bao. 2012 Dec 25;64(6):700-6.

Implications of calpains in health and diseases

Chakraborti S, Alam MN, Paik D, Shaikh S, Chakraborti T.

Indian J Biochem Biophys. 2012 Oct;49(5):316-28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias